Potent infiltration of NK-92/9.28.z cells reduced the tumor development along with boosted tumor cell eradication in the GPC3-positive HCC xenografts, which suggested clinical efficacy of GPC3-specific NK-92/9.28.z cell in HCC (83). The gene discussed is GPC3; the disease is hepatocellular carcinoma.